Beatrix Schnorr

1.2k total citations
21 papers, 787 citations indexed

About

Beatrix Schnorr is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, Beatrix Schnorr has authored 21 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 3 papers in Rheumatology. Recurrent topics in Beatrix Schnorr's work include Coronary Interventions and Diagnostics (14 papers), Peripheral Artery Disease Management (13 papers) and Cerebrovascular and Carotid Artery Diseases (8 papers). Beatrix Schnorr is often cited by papers focused on Coronary Interventions and Diagnostics (14 papers), Peripheral Artery Disease Management (13 papers) and Cerebrovascular and Carotid Artery Diseases (8 papers). Beatrix Schnorr collaborates with scholars based in Germany, Malaysia and Switzerland. Beatrix Schnorr's co-authors include Thomas Albrecht, Bruno Scheller, Ulrich Speck, Gunnar Tepe, Thomas Zeller, Klaus Brechtel, Claus D. Claussen, Heiner Stiepani, Enrique Lopez Hänninen and Michael Werk and has published in prestigious journals such as PLoS ONE, Journal of Biomedical Optics and JACC: Cardiovascular Interventions.

In The Last Decade

Beatrix Schnorr

20 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beatrix Schnorr Germany 10 742 600 112 98 70 21 787
Anthony Ragheb United States 10 1.0k 1.4× 893 1.5× 143 1.3× 97 1.0× 26 0.4× 15 1.1k
Philipp J. Schaefer Germany 10 417 0.6× 342 0.6× 72 0.6× 37 0.4× 47 0.7× 18 491
Bettina Kelsch Germany 10 509 0.7× 279 0.5× 22 0.2× 182 1.9× 195 2.8× 15 563
Irene Boos Germany 11 287 0.4× 246 0.4× 42 0.4× 35 0.4× 30 0.4× 16 349
Luigi Inglese Italy 15 480 0.6× 575 1.0× 16 0.1× 315 3.2× 60 0.9× 47 769
Matthias Waliszewski Germany 13 905 1.2× 384 0.6× 30 0.3× 524 5.3× 378 5.4× 57 965
Alberto Benassi Italy 12 349 0.5× 146 0.2× 43 0.4× 366 3.7× 97 1.4× 20 473
Alexander S. Tretinyak United States 12 229 0.3× 137 0.2× 61 0.5× 100 1.0× 15 0.2× 17 352
Michael Pieper Germany 10 632 0.9× 184 0.3× 125 1.1× 589 6.0× 296 4.2× 14 850
Hosam F. El-Sayed United States 13 300 0.4× 354 0.6× 66 0.6× 91 0.9× 10 0.1× 35 441

Countries citing papers authored by Beatrix Schnorr

Since Specialization
Citations

This map shows the geographic impact of Beatrix Schnorr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatrix Schnorr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatrix Schnorr more than expected).

Fields of papers citing papers by Beatrix Schnorr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatrix Schnorr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatrix Schnorr. The network helps show where Beatrix Schnorr may publish in the future.

Co-authorship network of co-authors of Beatrix Schnorr

This figure shows the co-authorship network connecting the top 25 collaborators of Beatrix Schnorr. A scholar is included among the top collaborators of Beatrix Schnorr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatrix Schnorr. Beatrix Schnorr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheller, Bruno, Norman Mangner, Raban Jeger, et al.. (2024). A randomised trial of sirolimus- versus paclitaxel-coated balloons for de novo coronary lesions. EuroIntervention. 20(21). e1322–e1329. 7 indexed citations
2.
Schnorr, Beatrix, et al.. (2023). One single drug-coated balloon for all shapes/diameters? Neointimal proliferation inhibition in porcine peripheral arteries. PLoS ONE. 18(1). e0280206–e0280206. 1 indexed citations
3.
Gemeinhardt, Ole, Tobias Haase, Beatrix Schnorr, et al.. (2022). Improvement of Outcome for Treatment of ‘Restenosis-prone’ Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries. CardioVascular and Interventional Radiology. 45(12). 1822–1831. 5 indexed citations
4.
Haase, Tobias, Ulrich Speck, Ole Gemeinhardt, et al.. (2022). Drug-Coated Balloons: Drugs Beyond Paclitaxel?. Frontiers in Bioscience-Landmark. 27(10). 283–283. 1 indexed citations
5.
Gemeinhardt, Ole, Beatrix Schnorr, Ulrich Speck, & Bruno Scheller. (2021). A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions. PLoS ONE. 16(10). e0259106–e0259106. 3 indexed citations
6.
Haase, Tobias, et al.. (2021). Preclinical Evaluation of the Temporary Drug-Coated Spur Stent System in Porcine Peripheral Arteries. Journal of Endovascular Therapy. 28(6). 938–949. 4 indexed citations
7.
Ali, Rosli Mohd, Wan Azman Wan Ahmad, Tiong Kiam Ong, et al.. (2019). Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon. JACC: Cardiovascular Interventions. 12(6). 558–566. 101 indexed citations
9.
Tepe, Gunnar, Özlem Gögebakan, J. Tautenhahn, et al.. (2017). Angiographic and Clinical Outcomes After Treatment of Femoro-Popliteal Lesions with a Novel Paclitaxel-Matrix-Coated Balloon Catheter. CardioVascular and Interventional Radiology. 40(10). 1535–1544. 41 indexed citations
10.
Garcia, Stephan Rodrigo Marticorena, et al.. (2016). Use of Paclitaxel-Coated Balloon Catheter Dilation to Reduce In-Stent Restenosis in Transjugular Intrahepatic Portosystemic Shunt (TIPS). RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 188(4). 374–380. 2 indexed citations
11.
Tepe, Gunnar, Beatrix Schnorr, Thomas Albrecht, et al.. (2015). Angioplasty of Femoral-Popliteal Arteries With Drug-Coated Balloons. JACC: Cardiovascular Interventions. 8(1). 102–108. 190 indexed citations
12.
Gemeinhardt, Ines, et al.. (2014). In vivotherapy monitoring of experimental rheumatoid arthritis in rats using near-infrared fluorescence imaging. Journal of Biomedical Optics. 19(3). 36011–36011. 3 indexed citations
13.
Tepe, Gunnar, Thomas Zeller, Beatrix Schnorr, et al.. (2013). High-Grade, Non-Flow-Limiting Dissections Do Not Negatively Impact Long-term Outcome After Paclitaxel-Coated Balloon Angioplasty: An Additional Analysis From the THUNDER Study. Journal of Endovascular Therapy. 20(6). 792–800. 51 indexed citations
14.
Schnorr, Beatrix & Thomas Albrecht. (2013). Drug-coated balloons and their place in treating peripheral arterial disease. Expert Review of Medical Devices. 10(1). 105–114. 14 indexed citations
16.
Werk, Michael, Thomas Albrecht, Ulrich A. Dietz, et al.. (2012). Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal Angioplasty. Circulation Cardiovascular Interventions. 5(6). 831–840. 278 indexed citations
17.
Scheller, Bruno, Bodo Cremers, Stephanie Schmitmeier, et al.. (2010). Drug-coated Balloons – History and Peripheral Vascular Opportunities. Interventional Cardiology Reviews Research Resources. 5(1). 70–70. 1 indexed citations
18.
Schnorr, Beatrix, et al.. (2010). Contemporary issues in cardiac pacing.. PubMed. 58(6). 677–90.
19.
Tepe, Gunnar, Stephanie Schmitmeier, Ulrich Speck, et al.. (2010). Advances on drug-coated balloons.. PubMed. 51(1). 125–43. 12 indexed citations
20.
Schnorr, Beatrix, Bettina Kelsch, Bodo Cremers, et al.. (2010). Paclitaxel-coated balloons - Survey of preclinical data.. PubMed. 58(5). 567–82. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026